The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.

In late-stage disease, PDPN expression was a highly significant risk factor for stage IV ( S1B Fig ), but not for stage III CRC patients ( Table 2 ).

also in 132,142 other papers